BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 23174100)

  • 1. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
    Wang Y; Wang X; Zhao H; Liang B; Du Q
    J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis.
    Wang Y; Yue B; Yu X; Wang Z; Wang M
    World J Surg Oncol; 2013 Jan; 11():12. PubMed ID: 23339680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.
    Zoubeidi A; Ettinger S; Beraldi E; Hadaschik B; Zardan A; Klomp LW; Nelson CC; Rennie PS; Gleave ME
    Mol Cancer Res; 2010 Jan; 8(1):119-30. PubMed ID: 20068069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
    Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin Reduces Cold Ischemia-Reperfusion Injury in Heart Transplantation Through Regulation of NF-kB Signaling and Bax/Bcl-xL Expression.
    Liu G; Zhang H; Hao F; Hao J; Pan L; Zhao Q; Wo J
    Cell Physiol Biochem; 2018; 45(3):1003-1012. PubMed ID: 29428944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.
    Prochnow H; Gollan R; Rohne P; Hassemer M; Koch-Brandt C; Baiersdörfer M
    PLoS One; 2013; 8(9):e75303. PubMed ID: 24073260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas.
    Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alpha.
    Yan D; Qin N; Zhang H; Liu T; Yu M; Jiang X; Feng W; Wang J; Yin B; Zhang T; Zhou M; Li Z
    Breast Cancer Res Treat; 2009 Jul; 116(1):91-102. PubMed ID: 18618239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NF-kappaB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis.
    Takase O; Minto AW; Puri TS; Cunningham PN; Jacob A; Hayashi M; Quigg RJ
    Kidney Int; 2008 Mar; 73(5):567-77. PubMed ID: 18075502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin silencing inhibits proliferation and reduces invasion in human laryngeal squamous carcinoma cells.
    Wang Q; Cao W; Su Q; Liu Z; Zhang L
    World J Surg Oncol; 2014 Apr; 12():124. PubMed ID: 24767179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
    Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
    Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB RNAi decreases the Bax/Bcl-2 ratio and inhibits TNF-α-induced apoptosis in human alveolar epithelial cells.
    Li L; Wu W; Huang W; Hu G; Yuan W; Li W
    Inflamm Res; 2013 Apr; 62(4):387-97. PubMed ID: 23334076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of Bcl-2 is mediated by NF-κB activation in Helicobacter pylori-induced apoptosis of gastric epithelial cells.
    Chu SH; Lim JW; Kim DG; Lee ES; Kim KH; Kim H
    Scand J Gastroenterol; 2011 Feb; 46(2):148-55. PubMed ID: 20969490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.
    Abo-Elfadl MT; Gamal-Eldeen AM; Ismail MF; Shahin NN
    Cytokine; 2020 Jan; 125():154790. PubMed ID: 31400636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.